Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis

Li Luan,Shixin Han,Hua Wang,Xiaoming Liu

International Immunopharmacology（2015）

引用 46|浏览6

暂无评分

摘要

•Th1, Th17, and Th22 cells are involved in the pathogenesis of psoriasis.•Adalimumab is effective in treating psoriasis.•Adalimumab disrupts the Th1, Th17 and Th22 pathways.

查看译文

关键词

Psoriasis,Anti-tnfα,Adalimumab,Th1 cell,Th17 cell,Th22 cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要